Journal Article
. 2009 Jan; 360(6):626-33.
doi: 10.1056/NEJMhpr0807774.

Limits on Medicare's ability to control rising spending on cancer drugs

Peter B Bach 1 
Affiliations
  • PMID: 19176475
  •     129 citations

No abstract available

Controlling the cost of innovative cancer therapeutics.
Nafees N Malik.
Nat Rev Clin Oncol, 2009 Aug 27; 6(9). PMID: 19707244
Review.
Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
Vassiliki Kotoula, Elpida Charalambous, +4 authors, George Karkavelas.
PLoS One, 2009 Nov 06; 4(11). PMID: 19888477    Free PMC article.
Expensive cancer drugs: a comparison between the United States and the United Kingdom.
Ruth R Faden, Kalipso Chalkidou, +2 authors, Jonathon P Leider.
Milbank Q, 2009 Dec 22; 87(4). PMID: 20021586    Free PMC article.
When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology.
Dan Greenberg, Craig Earle, +2 authors, Peter J Neumann.
J Natl Cancer Inst, 2010 Jan 09; 102(2). PMID: 20056956    Free PMC article.
Review.
Making longevity in an aging society: linking ethical sensibility and Medicare spending.
Sharon R Kaufman.
Med Anthropol, 2010 Feb 26; 28(4). PMID: 20182967    Free PMC article.
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.
Hans-Georg Eichler, Brigitte Bloechl-Daum, +3 authors, Steven Pearson.
Nat Rev Drug Discov, 2010 Feb 27; 9(4). PMID: 20186141
Review.
Cancer's next frontier: addressing high and increasing costs.
Elena B Elkin, Peter B Bach.
JAMA, 2010 Mar 18; 303(11). PMID: 20233828    Free PMC article.
Targeted cancer therapies.
Saurabh Aggarwal.
Nat Rev Drug Discov, 2010 Jun 02; 9(6). PMID: 20514063
Impact of the cost of cancer treatment: an internet-based survey.
Maurie Markman, Ryan Luce.
J Oncol Pract, 2010 Jul 02; 6(2). PMID: 20592778    Free PMC article.
Towards patient-based cancer therapeutics.
Cancer Target Discovery and Development Network, Stuart L Schreiber, +37 authors, Bruce A Posner.
Nat Biotechnol, 2010 Sep 11; 28(9). PMID: 20829823    Free PMC article.
Advances in cancer therapeutics and patient access to new drugs.
George Dranitsaris, Ilse Truter, +2 authors, William Evans.
Pharmacoeconomics, 2010 Dec 28; 29(3). PMID: 21184619
Review.
Projections of the cost of cancer care in the United States: 2010-2020.
Angela B Mariotto, K Robin Yabroff, +2 authors, Martin L Brown.
J Natl Cancer Inst, 2011 Jan 14; 103(2). PMID: 21228314    Free PMC article.
Highly Cited.
Initial patterns of care with oral targeted therapies for patients with renal cell carcinoma.
Christopher P Filson, Bruce G Redman, Rodney L Dunn, David C Miller.
Urology, 2011 Jan 25; 77(4). PMID: 21256539    Free PMC article.
Bending the cost curve in cancer care.
Thomas J Smith, Bruce E Hillner.
N Engl J Med, 2011 May 27; 364(21). PMID: 21612477    Free PMC article.
Highly Cited.
Medicare, ethics, and reflexive longevity: governing time and treatment in an aging society.
Sharon R Kaufman, Lakshmi Fjord.
Med Anthropol Q, 2011 Aug 13; 25(2). PMID: 21834359    Free PMC article.
Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
Michael Grabner, Eberechukwu Onukwugha, Rahul Jain, C Daniel Mullins.
J Oncol Pract, 2011 Sep 03; 7(3 Suppl). PMID: 21886506    Free PMC article.
Economic burden of cancer in the United States: estimates, projections, and future research.
K Robin Yabroff, Jennifer Lund, Deanna Kepka, Angela Mariotto.
Cancer Epidemiol Biomarkers Prev, 2011 Oct 08; 20(10). PMID: 21980008    Free PMC article.
Highly Cited.
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
Rosa Lerose, Pellegrino Musto, +2 authors, Alfredo Tartarone.
Eur J Clin Pharmacol, 2011 Dec 15; 68(5). PMID: 22166932
Review.
The economic pressures for biosimilar drug use in cancer medicine.
Paul Cornes.
Target Oncol, 2012 Jan 18; 7 Suppl 1. PMID: 22249658    Free PMC article.
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Michael T Eaddy, Christopher L Cook, +2 authors, C Ron Cantrell.
P T, 2012 Feb 22; 37(1). PMID: 22346336    Free PMC article.
A way forward on the medically appropriate use of white cell growth factors.
Thomas J Smith, Bruce E Hillner.
J Clin Oncol, 2012 Mar 01; 30(14). PMID: 22370327    Free PMC article.
Review.
Improving quality and addressing the rising costs of cancer care: two birds, one stone.
Jason Luke, Joshua Mirkin, Peter Bach.
J Oncol Pract, 2012 Mar 02; 7(6). PMID: 22379427    Free PMC article.
A model to estimate human resource needs for the treatment of outpatients with cancer.
Gianpiero Fasola, Giuseppe Aprile, Marianna Aita.
J Oncol Pract, 2012 May 02; 8(1). PMID: 22548005    Free PMC article.
International variability in the reimbursement of cancer drugs by publically funded drug programs.
P K Cheema, S Gavura, +3 authors, M E Trudeau.
Curr Oncol, 2012 Jun 07; 19(3). PMID: 22670106    Free PMC article.
Finasteride and prostate cancer: a commentary.
Channing J Paller, Thomas J Smith.
Oncologist, 2012 Jun 23; 17(7). PMID: 22723510    Free PMC article.
The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals.
P J Lachmann.
QJM, 2012 Aug 22; 105(12). PMID: 22908318    Free PMC article.
Infused chemotherapy use in the elderly after patent expiration.
Rena M Conti, Meredith B Rosenthal, +2 authors, Ya-Chen Tina Shih.
J Oncol Pract, 2012 Sep 04; 8(3 Suppl). PMID: 22942829    Free PMC article.
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.
Bruce A Feinberg, James Lang, +8 authors, Jeffrey A Scott.
J Oncol Pract, 2012 Sep 04; 8(3 Suppl). PMID: 22942833    Free PMC article.
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.
Robert I Griffiths, Michelle L Gleeson, Joseph Mikhael, Mark D Danese.
J Cancer Epidemiol, 2012 Sep 13; 2012. PMID: 22969803    Free PMC article.
A framework for understanding cancer comparative effectiveness research data needs.
William R Carpenter, Anne-Marie Meyer, +2 authors, Michael R Kosorok.
J Clin Epidemiol, 2012 Sep 29; 65(11). PMID: 23017633    Free PMC article.
The high cost of cancer drugs and what we can do about it.
Mustaqeem Siddiqui, S Vincent Rajkumar.
Mayo Clin Proc, 2012 Oct 06; 87(10). PMID: 23036669    Free PMC article.
Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
Steven D Pearson.
J Clin Oncol, 2012 Oct 17; 30(34). PMID: 23071229    Free PMC article.
Review.
Physician response to financial incentives when choosing drugs to treat breast cancer.
Andrew J Epstein, Scott J Johnson.
Int J Health Care Finance Econ, 2012 Nov 06; 12(4). PMID: 23124970
Efficient allocation of novel agents in multiple myeloma: a work in progress.
Jennifer G Gaultney, Carin A Uyl-de Groot.
Oncologist, 2013 Jan 10; 18(1). PMID: 23299778    Free PMC article.
The cost of breast cancer screening in the Medicare population.
Cary P Gross, Jessica B Long, +6 authors, Xiaomei Ma.
JAMA Intern Med, 2013 Jan 11; 173(3). PMID: 23303200    Free PMC article.
Out of pocket, out of sight? An unmeasured component of the burden of cancer.
Matthew P Banegas, K Robin Yabroff.
J Natl Cancer Inst, 2013 Jan 26; 105(4). PMID: 23349251    Free PMC article.
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.
Rena M Conti, Arielle C Bernstein, +3 authors, Peter B Bach.
J Clin Oncol, 2013 Feb 21; 31(9). PMID: 23423747    Free PMC article.
The timing of drug funding announcements relative to elections: a case study involving dementia medications.
Sudeep S Gill, Neeraj Gupta, +3 authors, Andreas Laupacis.
PLoS One, 2013 Mar 06; 8(2). PMID: 23460820    Free PMC article.
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines.
Amy J Davidoff, Sheila R Weiss, +4 authors, Steven D Gore.
Leuk Res, 2013 Mar 26; 37(6). PMID: 23523473    Free PMC article.
Financial toxicity, Part I: a new name for a growing problem.
S Yousuf Zafar, Amy P Abernethy.
Oncology (Williston Park), 2013 Mar 28; 27(2). PMID: 23530397    Free PMC article.
Highly Cited.
Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review.
J S Hoch, M Sabharwal.
Curr Oncol, 2013 Apr 06; 20(2). PMID: 23559876    Free PMC article.
Cancer drugs in the United States: Justum Pretium--the just price.
Hagop M Kantarjian, Tito Fojo, Michael Mathisen, Leonard A Zwelling.
J Clin Oncol, 2013 May 08; 31(28). PMID: 23650428    Free PMC article.
Highly Cited.
Advancing comparative studies of patterns of care and economic outcomes in cancer: challenges and opportunities.
K Robin Yabroff, Silvia Francisci, +3 authors, Joseph Lipscomb.
J Natl Cancer Inst Monogr, 2013 Aug 22; 2013(46). PMID: 23962506    Free PMC article.
Initial treatment for newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States.
Anna Gigli, Joan L Warren, +8 authors, Angela Mariotto.
J Natl Cancer Inst Monogr, 2013 Aug 22; 2013(46). PMID: 23962512    Free PMC article.
Appraising iniparib, the PARP inhibitor that never was--what must we learn?
Joaquin Mateo, Michael Ong, +2 authors, Johann S de Bono.
Nat Rev Clin Oncol, 2013 Oct 17; 10(12). PMID: 24129347
Review.
Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.
Dan Greenberg, Ariel Hammerman, +3 authors, Peter J Neumann.
Isr J Health Policy Res, 2013 Nov 20; 2. PMID: 24245811    Free PMC article.
Publication patterns of cancer cost-effectiveness studies presented at major conferences.
K K Chan, E Siu, L Mozessohn, M C Cheung.
Curr Oncol, 2013 Dec 07; 20(6). PMID: 24311947    Free PMC article.
Drug waste minimization as an effective strategy of cost-containment in oncology.
Gianpiero Fasola, Giuseppe Aprile, +3 authors, Manuela Miscoria.
BMC Health Serv Res, 2014 Feb 11; 14. PMID: 24507545    Free PMC article.
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.
M Joerger, C Schaer-Thuer, +5 authors, T Cerny.
Eur J Clin Pharmacol, 2014 Mar 13; 70(6). PMID: 24609468
Relevance of health economics in breast cancer treatment: integration of economics in the management of breast cancer at the clinic level.
Volker R Jacobs, Gerhard Bogner, +2 authors, Thorsten Fischer.
Breast Care (Basel), 2014 Apr 10; 8(1). PMID: 24715837    Free PMC article.
Review.
Principles and reality of proton therapy treatment allocation.
Justin E Bekelman, David A Asch, +5 authors, Stephen M Hahn.
Int J Radiat Oncol Biol Phys, 2014 May 07; 89(3). PMID: 24798985    Free PMC article.
A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.
Panagiotis Petrou, Michael A Talias.
Cost Eff Resour Alloc, 2014 Jun 10; 12. PMID: 24910539    Free PMC article.
Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
Rhonda Greenapple.
Am Health Drug Benefits, 2012 Jul 01; 5(4). PMID: 24991323    Free PMC article.
Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer.
Veena Shankaran, David Mummy, +6 authors, Scott D Ramsey.
Oncologist, 2014 Aug 03; 19(8). PMID: 25085899    Free PMC article.
It's time to have 'the talk': cost communication and patient-centered care.
S Yousuf Zafar, James A Tulsky, Amy P Abernethy.
Oncology (Williston Park), 2014 Aug 20; 28(6). PMID: 25134320    Free PMC article.
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.
Ethan Basch, D Andrew Loblaw, +17 authors, Katherine S Virgo.
J Clin Oncol, 2014 Sep 10; 32(30). PMID: 25199761    Free PMC article.
Highly Cited. Systematic Review.
National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.
Rena M Conti, Adam J Fein, Sumita S Bhatta.
Health Aff (Millwood), 2014 Oct 08; 33(10). PMID: 25288415    Free PMC article.
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs.
Carol Sunghye Lim, Yun-Gyoo Lee, Youngil Koh, Dae Seog Heo.
BMC Health Serv Res, 2014 Nov 30; 14. PMID: 25432511    Free PMC article.
Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.
Daniel M Geynisman, Chun-Ru Chien, +2 authors, Ya-Chen Tina Shih.
Hum Vaccin Immunother, 2014 Dec 09; 10(11). PMID: 25483656    Free PMC article.
Systematic Review.
Cancer Treatment: The Cost Factor.
S Smith.
West Indian Med J, 2015 Apr 14; 63(7). PMID: 25867563    Free PMC article.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Daniel M Hartung, Dennis N Bourdette, Sharia M Ahmed, Ruth H Whitham.
Neurology, 2015 Apr 26; 84(21). PMID: 25911108    Free PMC article.
Highly Cited.
Challenges and opportunities in measuring cancer recurrence in the United States.
Joan L Warren, K Robin Yabroff.
J Natl Cancer Inst, 2015 May 15; 107(8). PMID: 25971299    Free PMC article.
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011.
Ya-Chen Tina Shih, Fabrice Smieliauskas, +2 authors, Thomas J Smith.
J Clin Oncol, 2015 May 20; 33(19). PMID: 25987701    Free PMC article.
Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.
Blase Polite, Rena M Conti, Jeffery C Ward.
Am Soc Clin Oncol Educ Book, 2015 May 21;. PMID: 25993241    Free PMC article.
Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.
Ronan J Kelly, Patrick M Forde, +3 authors, Thomas J Smith.
J Oncol Pract, 2015 May 28; 11(4). PMID: 26015459    Free PMC article.
A Time-Trend Economic Analysis of Cancer Drug Trials.
Sonya Cressman, George P Browman, +2 authors, Stuart J Peacock.
Oncologist, 2015 Jun 03; 20(7). PMID: 26032135    Free PMC article.
Cost Considerations in the Evaluation and Treatment of Colorectal Cancer.
Veena Shankaran.
Curr Treat Options Oncol, 2015 Jul 15; 16(8). PMID: 26162432
Review.
Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.
Daniel A Goldstein, Bilal B Ahmad, +5 authors, Christopher R Flowers.
J Clin Oncol, 2015 Aug 26; 33(32). PMID: 26304904    Free PMC article.
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review.
Aaron N Winn, Donatus U Ekwueme, Gery P Guy, Peter J Neumann.
Am J Prev Med, 2015 Oct 17; 50(2). PMID: 26470806    Free PMC article.
Systematic Review.
Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy.
Stacie B Dusetzina, Nancy L Keating.
J Clin Oncol, 2015 Dec 09; 34(4). PMID: 26644524    Free PMC article.
Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data.
Mark D Danese, Carolina M Reyes, +3 authors, Joseph Mikhael.
Med Care, 2016 Jan 14; 54(4). PMID: 26759977    Free PMC article.
Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis.
Ursula Rochau, Martina Kluibenschaedl, +5 authors, Uwe Siebert.
Leuk Res Treatment, 2016 Jan 20; 2015. PMID: 26783469    Free PMC article.
ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.
Caitriona B O'Neill, Coral L Atoria, +9 authors, Elena B Elkin.
J Oncol Pract, 2016 Feb 13; 12(2). PMID: 26869655    Free PMC article.
The changing landscape of biosimilars in rheumatology.
Thomas Dörner, Vibeke Strand, +7 authors, Gerd R Burmester.
Ann Rheum Dis, 2016 Mar 11; 75(6). PMID: 26964144    Free PMC article.
Highly Cited. Review.
Population-based trends in systemic therapy use and cost for cancer patients in the last year of life.
R E Pataky, W Y Cheung, +5 authors, S J Peacock.
Curr Oncol, 2016 Mar 18; 23(Suppl 1). PMID: 26985144    Free PMC article.
Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.
Allison Lipitz-Snyderman, Camelia S Sima, +6 authors, Peter B Bach.
JAMA Intern Med, 2016 Aug 18; 176(10). PMID: 27533635    Free PMC article.
A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients?
Dana S Wollins, S Yousuf Zafar.
Oncologist, 2016 Aug 24; 21(10). PMID: 27551014    Free PMC article.
Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change.
Rena M Conti.
J Oncol Pract, 2015 Jan 01; 11(1). PMID: 27608496    Free PMC article.
Trends in annual drug expenditure - a 16 year perspective of a public healthcare maintenance organization.
Yossef Lomnicky, Daniel Kurnik, +3 authors, Nava Siegelmann-Danieli.
Isr J Health Policy Res, 2016 Sep 22; 5. PMID: 27651890    Free PMC article.
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual.
Chad Tang, Kenneth R Hess, +6 authors, David S Hong.
Clin Cancer Res, 2016 Nov 18; 23(6). PMID: 27852698    Free PMC article.
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.
Qiushi Chen, Nitin Jain, +6 authors, Jagpreet Chhatwal.
J Clin Oncol, 2016 Nov 22; 35(2). PMID: 27870563    Free PMC article.
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.
Aaron N Winn, Nancy L Keating, Stacie B Dusetzina.
J Clin Oncol, 2016 Dec 22; 34(36). PMID: 27998234    Free PMC article.
A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Clare T Butler, Alison L Reynolds, +5 authors, Breandán N Kennedy.
J Biol Chem, 2016 Dec 31; 292(9). PMID: 28035003    Free PMC article.
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
Christine G Kohn, Simon B Zeichner, +3 authors, Christopher R Flowers.
J Clin Oncol, 2017 Feb 22; 35(11). PMID: 28221865    Free PMC article.
Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
Ildar Akhmetov, Rostyslav V Bubnov.
EPMA J, 2017 Feb 24; 8(1). PMID: 28228864    Free PMC article.
Review.
Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
Chad Tang, Steven I Sherman, +7 authors, J Jack Lee.
Clin Cancer Res, 2017 Mar 10; 23(6). PMID: 28275168    Free PMC article.
The high price of anticancer drugs: origins, implications, barriers, solutions.
Vinay Prasad, Kevin De Jesús, Sham Mailankody.
Nat Rev Clin Oncol, 2017 Mar 16; 14(6). PMID: 28290490
Highly Cited. Review.
Low-value practices in oncology contributing to financial toxicity.
Bishal Gyawali.
Ecancermedicalscience, 2017 Apr 08; 11. PMID: 28386297    Free PMC article.
Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma.
Adam J Olszewski, Stacie B Dusetzina, +2 authors, Amal N Trivedi.
J Clin Oncol, 2017 May 26; 35(29). PMID: 28541791    Free PMC article.
Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.
Stacie B Dusetzina, Rena M Conti, Nancy L Yu, Peter B Bach.
JAMA Intern Med, 2017 May 31; 177(8). PMID: 28558108    Free PMC article.
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
Lucy Hui, Gottfried von Keudell, +5 authors, Scott F Huntington.
Cancer, 2017 Jun 24; 123(19). PMID: 28640385    Free PMC article.
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Katherine D Crew, Kathy S Albain, +2 authors, Shelly S Lo.
NPJ Breast Cancer, 2017 Jun 27; 3. PMID: 28649660    Free PMC article.
Me, Too.
Bishal Gyawali.
J Glob Oncol, 2016 Jan 20; 2(3). PMID: 28717688    Free PMC article.
Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012.
Maryam Mohammadian, Reza Pakzad, +3 authors, Hamid Salehiniya.
Clujul Med, 2017 Aug 07; 90(3). PMID: 28781525    Free PMC article.
Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.
Qiushi Chen, Ashley D Staton, +3 authors, Christopher R Flowers.
Leuk Lymphoma, 2017 Oct 27; 59(7). PMID: 29065744    Free PMC article.
Cost of Care for the Initial Management of Ovarian Cancer.
Alexandra S Bercow, Ling Chen, +7 authors, Jason D Wright.
Obstet Gynecol, 2017 Nov 08; 130(6). PMID: 29112648    Free PMC article.
Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States.
Helen M Parsons, Quyen Chu, +2 authors, Linda C Harlan.
Liver Cancer, 2017 Dec 14; 6(3). PMID: 29234628    Free PMC article.
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.
Colene Bentley, Sarah Costa, +3 authors, Stuart J Peacock.
BMC Health Serv Res, 2018 May 10; 18(1). PMID: 29739463    Free PMC article.
THE LOCAL INFLUENCE OF PIONEER INVESTIGATORS ON TECHNOLOGY ADOPTION: EVIDENCE FROM NEW CANCER DRUGS.
Leila Agha, David Molitor.
Rev Econ Stat, 2018 May 15; 100(1). PMID: 29755142    Free PMC article.
Financial toxicity and implications for cancer care in the era of molecular and immune therapies.
George Tran, S Yousuf Zafar.
Ann Transl Med, 2018 Jun 19; 6(9). PMID: 29911114    Free PMC article.
Review.
Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides.
Priyanka Bhatt, Manoj Kumar, Anjali Jha.
Mol Divers, 2018 Jun 28; 22(4). PMID: 29948580
Economic Impact of Oral Therapies for Chronic Lymphocytic Leukemia-the Burden of Novelty.
Talal Hilal, Jeffrey A Betcher, Jose F Leis.
Curr Hematol Malig Rep, 2018 Jul 10; 13(4). PMID: 29982866
Review.
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.
Patricia M Danzon.
Pharmacoeconomics, 2018 Aug 01; 36(12). PMID: 30062518
Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.
Scott F Huntington, Gottfried von Keudell, +2 authors, Sapna A Prasad.
J Clin Oncol, 2018 Oct 05;. PMID: 30285558    Free PMC article.
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are Going.
Anureet C Copeland, Carey K Anders.
Oncology (Williston Park), 2018 Oct 20; 32(10). PMID: 30334236    Free PMC article.
Review.
Trends in Antineoplastic Receipt after Medicare Payment Reform: Implications for Future Oncology Payment Design.
Helen M Parsons, Susanne Schmidt, Laura L Tenner, Amy J Davidoff.
J Cancer Policy, 2018 Oct 23; 17. PMID: 30345223    Free PMC article.
Value-based medicine in oncology: the importance of perspective in the emerging value frameworks.
Alessandro Gonçalves Campolina.
Clinics (Sao Paulo), 2018 Dec 13; 73(suppl 1). PMID: 30540119    Free PMC article.
Review.
Understanding primary care-oncology relationships within a changing healthcare environment.
Jennifer Tsui, Jenna Howard, +6 authors, Benjamin F Crabtree.
BMC Fam Pract, 2019 Nov 30; 20(1). PMID: 31775653    Free PMC article.
Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment.
Scott F Huntington.
Hematology Am Soc Hematol Educ Program, 2019 Dec 07; 2019(1). PMID: 31808838    Free PMC article.
Review.
The long-term effects of cancer survivorship on household assets.
Tae-Young Pak, Hyungsoo Kim, Kyoung Tae Kim.
Health Econ Rev, 2020 Jan 15; 10(1). PMID: 31933035    Free PMC article.
Potential Life-Years Lost: The Impact of the Cancer Drug Regulatory and Funding Process in Canada.
Joanna Gotfrit, John J W Shin, +2 authors, Paul Wheatley-Price.
Oncologist, 2019 Sep 12; 25(1). PMID: 31506392    Free PMC article.
Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
Aaron P Mitchell, Alan C Kinlaw, +3 authors, Jennifer L Lund.
Oncologist, 2019 Oct 16; 25(1). PMID: 31611329    Free PMC article.
Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria.
M S Lim, Thomas Beyer, +25 authors, M Hacker.
Mol Imaging Biol, 2019 May 03; 22(1). PMID: 31049831
Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.
Gerson Hiroshi Yoshinari, Artur César Fassoni, Luis Fernando Mello, Eduardo M Rego.
PLoS One, 2019 Aug 16; 14(8). PMID: 31415632    Free PMC article.
Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
William A Stokes, Megan Eguchi, +5 authors, Sana D Karam.
Oral Oncol, 2018 Aug 18; 84. PMID: 30115470    Free PMC article.
The South Region Cancer Registry: an evaluation of its exhaustiveness in a cohort of lung cancer patients.
Jessica Verdasca, Filipa A Costa, +2 authors, Ana Miranda.
Thorac Cancer, 2018 Nov 30; 10(2). PMID: 30485701    Free PMC article.
Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
K Robin Yabroff, Jingxuan Zhao, +6 authors, Carrie N Klabunde.
J Natl Cancer Inst, 2019 Nov 02; 112(5). PMID: 31675070    Free PMC article.
Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach.
Michail Nikolaou, Georgios Nikolaou, +4 authors, Maria Tolia.
Integr Cancer Ther, 2019 Feb 23; 18. PMID: 30791740    Free PMC article.
Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
Katherine D Crew.
Am Soc Clin Oncol Educ Book, 2015 May 21;. PMID: 25993215    Free PMC article.
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.
Brian J Dahl.
Fed Pract, 2016 Jul 01; 33(7). PMID: 30766189    Free PMC article.
The Cost of Oncology Drugs: A Pharmacy Perspective, Part I.
Brian J Dahl.
Fed Pract, 2016 Feb 01; 33(Suppl 1). PMID: 30766201    Free PMC article.
Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention.
Katherine D Crew, Thomas B Silverman, +8 authors, Rita Kukafka.
Contemp Clin Trials Commun, 2019 Sep 10; 16. PMID: 31497674    Free PMC article.
Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.
Alice J Chen, Xiaohan Hu, +2 authors, Dana P Goldman.
Value Health, 2019 Dec 07; 22(12). PMID: 31806195    Free PMC article.
The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder.
CA Cancer J Clin, 2018 Jan 18; 68(2). PMID: 29338071    Free PMC article.
Highly Cited. Review.
Integrating Patient Incentives with Episode-Based Payment.
Lorens A Helmchen, William E Encinosa, Michael E Chernew, Richard A Hirth.
Forum Health Econ Policy, 2013 Jan 01; 16(1). PMID: 31032170    Free PMC article.
Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs.
Sarah Costa, Colene Bentley, +4 authors, Stuart J Peacock.
BMC Public Health, 2019 Jul 25; 19(1). PMID: 31331312    Free PMC article.
Association of Neighborhood Deprivation Index With Success in Cancer Care Crowdfunding.
Elisabeth R Silver, Han Q Truong, +2 authors, Nicholas P Tatonetti.
JAMA Netw Open, 2020 Dec 04; 3(12). PMID: 33270122    Free PMC article.
The Financial Burden of Cancer on Families in the United States.
Patrick Richard, Nilam Patel, +2 authors, Mustafa Younis.
Int J Environ Res Public Health, 2021 May 01; 18(7). PMID: 33916454    Free PMC article.
Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma.
Kathryn E Marqueen, Edward Kim, +3 authors, Bart S Ferket.
JCO Oncol Pract, 2021 Jan 09; 17(2). PMID: 33417490    Free PMC article.